Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

Jacqueline Saw; Eric J. Topol; Steven R. Steinhubl; Danielle Brennan; Peter B. Berger; David J. Moliterno

doi:10.1016/j.amjcard.2004.05.026

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

Jacqueline Saw, Eric J. Topol, Steven R. Steinhubl, Danielle Brennan, Peter B. Berger, David J. Moliterno

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

Patients in the Clopidogrel for the Reduction of Events During Observation trial were subgrouped according to whether they underwent index percutaneous coronary artery revascularization procedures only or this procedure plus subsequent percutaneous or surgical revascularization procedures during 1-year follow-up. The relative risk reduction in ischemic events associated with up-front and long-term clopidogrel compared with placebo was 2-fold greater in patients who required repeat revascularization procedures compared with those who did not (42.4% vs 21.7%).

Original language	English
Pages (from-to)	623-625
Number of pages	3
Journal	American Journal of Cardiology
Volume	94
Issue number	5
DOIs	https://doi.org/10.1016/j.amjcard.2004.05.026
State	Published - Sep 1 2004

Bibliographical note

Funding Information:
The CREDO trial was supported by Sanofi-Synthelabo, Inc./Bristol Myers Squibb Partnership, New York, New York.

Funding

The CREDO trial was supported by Sanofi-Synthelabo, Inc./Bristol Myers Squibb Partnership, New York, New York.

Funders	Funder number
Bristol Myers Squibb Partnership, New York, New York
Sanofi Synthelabo Inc

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2004.05.026

Cite this

Saw, J., Topol, E. J., Steinhubl, S. R., Brennan, D., Berger, P. B., & Moliterno, D. J. (2004). Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. American Journal of Cardiology, 94(5), 623-625. https://doi.org/10.1016/j.amjcard.2004.05.026

@article{2c6a6b7831af45c394d168154647df33,

title = "Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention",

abstract = "Patients in the Clopidogrel for the Reduction of Events During Observation trial were subgrouped according to whether they underwent index percutaneous coronary artery revascularization procedures only or this procedure plus subsequent percutaneous or surgical revascularization procedures during 1-year follow-up. The relative risk reduction in ischemic events associated with up-front and long-term clopidogrel compared with placebo was 2-fold greater in patients who required repeat revascularization procedures compared with those who did not (42.4\% vs 21.7\%).",

author = "Jacqueline Saw and Topol, \{Eric J.\} and Steinhubl, \{Steven R.\} and Danielle Brennan and Berger, \{Peter B.\} and Moliterno, \{David J.\}",

note = "Funding Information: The CREDO trial was supported by Sanofi-Synthelabo, Inc./Bristol Myers Squibb Partnership, New York, New York. ",

year = "2004",

month = sep,

day = "1",

doi = "10.1016/j.amjcard.2004.05.026",

language = "English",

volume = "94",

pages = "623--625",

number = "5",

}

Saw, J, Topol, EJ, Steinhubl, SR, Brennan, D, Berger, PB & Moliterno, DJ 2004, 'Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention', American Journal of Cardiology, vol. 94, no. 5, pp. 623-625. https://doi.org/10.1016/j.amjcard.2004.05.026

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. / Saw, Jacqueline; Topol, Eric J.; Steinhubl, Steven R. et al.
In: American Journal of Cardiology, Vol. 94, No. 5, 01.09.2004, p. 623-625.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

AU - Saw, Jacqueline

AU - Topol, Eric J.

AU - Steinhubl, Steven R.

AU - Brennan, Danielle

AU - Berger, Peter B.

AU - Moliterno, David J.

N1 - Funding Information: The CREDO trial was supported by Sanofi-Synthelabo, Inc./Bristol Myers Squibb Partnership, New York, New York.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Patients in the Clopidogrel for the Reduction of Events During Observation trial were subgrouped according to whether they underwent index percutaneous coronary artery revascularization procedures only or this procedure plus subsequent percutaneous or surgical revascularization procedures during 1-year follow-up. The relative risk reduction in ischemic events associated with up-front and long-term clopidogrel compared with placebo was 2-fold greater in patients who required repeat revascularization procedures compared with those who did not (42.4% vs 21.7%).

AB - Patients in the Clopidogrel for the Reduction of Events During Observation trial were subgrouped according to whether they underwent index percutaneous coronary artery revascularization procedures only or this procedure plus subsequent percutaneous or surgical revascularization procedures during 1-year follow-up. The relative risk reduction in ischemic events associated with up-front and long-term clopidogrel compared with placebo was 2-fold greater in patients who required repeat revascularization procedures compared with those who did not (42.4% vs 21.7%).

UR - https://www.scopus.com/pages/publications/4444338086

UR - https://www.scopus.com/inward/citedby.url?scp=4444338086&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2004.05.026

DO - 10.1016/j.amjcard.2004.05.026

M3 - Article

C2 - 15342293

AN - SCOPUS:4444338086

SN - 0002-9149

VL - 94

SP - 623

EP - 625

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 5

ER -

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

Abstract

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this